ATE170745T1 - Kapsel mit langzeitwirkung fuer die adhäsion im gastrointestinaltrakt - Google Patents

Kapsel mit langzeitwirkung fuer die adhäsion im gastrointestinaltrakt

Info

Publication number
ATE170745T1
ATE170745T1 AT92907990T AT92907990T ATE170745T1 AT E170745 T1 ATE170745 T1 AT E170745T1 AT 92907990 T AT92907990 T AT 92907990T AT 92907990 T AT92907990 T AT 92907990T AT E170745 T1 ATE170745 T1 AT E170745T1
Authority
AT
Austria
Prior art keywords
adhesion
capsule
long
gastrointestinal tract
term effect
Prior art date
Application number
AT92907990T
Other languages
English (en)
Inventor
Kouichi Nakamichi
Shogo Izumi
Hiroshi Fukui
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Application granted granted Critical
Publication of ATE170745T1 publication Critical patent/ATE170745T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92907990T 1991-04-08 1992-04-06 Kapsel mit langzeitwirkung fuer die adhäsion im gastrointestinaltrakt ATE170745T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10384691 1991-04-08

Publications (1)

Publication Number Publication Date
ATE170745T1 true ATE170745T1 (de) 1998-09-15

Family

ID=14364803

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92907990T ATE170745T1 (de) 1991-04-08 1992-04-06 Kapsel mit langzeitwirkung fuer die adhäsion im gastrointestinaltrakt

Country Status (8)

Country Link
US (1) US5498422A (de)
EP (1) EP0580861B1 (de)
JP (1) JP2626248B2 (de)
AT (1) ATE170745T1 (de)
AU (1) AU1560692A (de)
CA (1) CA2107678A1 (de)
DE (1) DE69226950T2 (de)
WO (1) WO1992017166A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2148470T3 (es) * 1993-12-10 2000-10-16 Fujisawa Pharmaceutical Co Farmaco analgesico antipiretico combinado.
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US6010711A (en) * 1996-01-26 2000-01-04 University Of Rochester Methods, articles and compositions for the pharmacologic inhibition of bone resorption with phosphodiesterase inhibitors
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US6210710B1 (en) * 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
US20020119192A1 (en) * 2000-09-22 2002-08-29 Vishwanathan Narayanan Badri Controlled release formulations for oral administration
BR0107304A (pt) * 2000-10-12 2002-08-13 Boehringer Ingelheim Pharma Pó para inalação contendo tiotrópio
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
AU2003225837B2 (en) * 2002-03-15 2008-11-06 Forest Laboratories Holdings Limited NE and 5-HT reuptake inhibitors for treating visceral pain syndromes
FR2838349B1 (fr) * 2002-04-15 2004-06-25 Laurence Paris Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication
US6986901B2 (en) * 2002-07-15 2006-01-17 Warner-Lambert Company Llc Gastrointestinal compositions
WO2004006902A1 (en) * 2002-07-10 2004-01-22 Warner-Lambert Company Llc Combination of an allosteric inhibitor or matrix metalloproteinase-13 with a selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib
US20040010035A1 (en) * 2002-07-15 2004-01-15 Ciociola Arthur A. Gastrointestinal compositions
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
AU2004207578B2 (en) * 2003-01-28 2007-06-28 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
CN101360485B (zh) * 2005-10-26 2013-04-17 班纳制药公司 作为胶囊填充物的基于亲水性载体的双重控释基质***
JP5406529B2 (ja) * 2005-10-26 2014-02-05 バナー ファーマキャプス， インコーポレイテッド カプセル充墳物としての親油性ベヒクルに基づく二重制御された放出マトリクスシステム
CN102438597A (zh) 2009-03-09 2012-05-02 丁内沙·沙蒂尔阿尔·帕特尔 一种选自中枢性作用肌弛缓药类型的化合物的新型缓释制剂
WO2012158648A1 (en) * 2011-05-13 2012-11-22 Massachusetts Institute Of Technology Method and apparatus for delivering a substance
ES2793530T3 (es) * 2014-05-19 2020-11-16 Tillotts Pharma Ag Cápsulas revestidas de liberación modificada
MX2017001625A (es) 2014-08-11 2017-07-28 Perora Gmbh Metodo para la induccion de saciedad.
PT3188717T (pt) 2014-08-11 2020-04-02 Perora Gmbh Formulação compreendendo partículas
CA2989520A1 (en) 2015-07-07 2017-01-12 Perora Gmbh Composition comprising satiety-inducing particles
WO2017005890A1 (en) 2015-07-07 2017-01-12 Perora Gmbh Method of inducing satiety

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002731A (en) * 1974-06-17 1977-01-11 Sterling Drug Inc. Diagnostic process using sodium tyropanoate
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
JPS587605B2 (ja) * 1977-09-08 1983-02-10 帝人株式会社 徐放性製剤およびその製造法
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
DE3400106A1 (de) * 1984-01-04 1985-07-11 Klaus-Dieter Dr. 3550 Marburg Bremecker Pharmazeutische zubereitungen mit gesteuerter arzneistoff-freisetzung
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
US5064650A (en) * 1988-04-19 1991-11-12 Southwest Research Institute Controlled-release salt sensitive capsule for oral use and adhesive system

Also Published As

Publication number Publication date
DE69226950D1 (de) 1998-10-15
CA2107678A1 (en) 1992-10-09
JP2626248B2 (ja) 1997-07-02
DE69226950T2 (de) 1999-05-12
AU1560692A (en) 1992-11-02
EP0580861A4 (de) 1994-03-21
EP0580861A1 (de) 1994-02-02
US5498422A (en) 1996-03-12
EP0580861B1 (de) 1998-09-09
WO1992017166A1 (en) 1992-10-15

Similar Documents

Publication Publication Date Title
ATE170745T1 (de) Kapsel mit langzeitwirkung fuer die adhäsion im gastrointestinaltrakt
ATE124255T1 (de) Im dickdarm zerfallende, polypeptide enthaltende orale formulierungen.
AU7992987A (en) Method and formulation for orally administering bioactive agents to and through the peyer's patch
FR2625217B1 (fr) Composition d'adhesif active sous l'effet de la pression a base de copolymere acrylique
EP0179023A3 (en) With micro-organisms degradable polypeptide, and its use for the progressive release of medicaments
ES2179829T3 (es) Preparacion de hidrogel de liberacion prolongada.
ATE127019T1 (de) Antazida-zubereitung mit verlängerter magenverweilzeit.
IT9067586A0 (it) Miscela polimerica amidacea particolarmente per la produzione di film e simili e procedimento per la sua produzione.
CA2174325A1 (en) Non-antigenic branched polymer conjugates
CA2416383A1 (en) Solution-, dispersion- or emulsion-producing film dermatics
CA2322579A1 (en) Gelling ophthalmic compositions containing xanthan gum
CA2235401A1 (en) Method for sterilizing medical devices utilizing a room temperature sterilant
NO944301L (no) Ikke-terapautisk mikrogranulært preparat
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
GB2375340B (en) Gelatin substitute
IT1229205B (it) Composizioni farmaceutiche agenti in particolare sul cuore e sul cuore e sul sistema cardiovascolare e procedimento per la loro preparazione.
DE69603129D1 (de) Drehender Verbinder mit kugelförmigem Kontakt
ES8700145A1 (es) Procedimiento para preparar tabletas que contienen un agente saporifero tal como aceite natural o sintetico y un polimero hidrofilo tal como polivinil pirrolidona.
IT1254898B (it) Idrogeli di tipo polietereammidoamminico come materiali eparinizzabili
DE3881279D1 (de) Bildsensor vom typ "direkter kontakt".
IT9047759A0 (it) Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare.
FR2718016B1 (fr) Dispositif externe permettant l'occlusion de l'urètre chez les incontinents de sexe masculin.
DE69617868D1 (de) Geschmacksmaskierte wässrige Lösungen enthaltend Ibuprofen und Menthol
FR2684848B1 (fr) Utilisation du glucomannane pour la preparation d'une gelee orale a effet de satiete et gelee orale comprenant du glucomannane a effet de satiete ainsi obtenue.
DE59104754D1 (de) Transparente, thermoplastische Polyetheresteramidimid-Elastomere sowie ihre Verwendung zur Herstellung von medizinischen Gebrauchsartikeln.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties